Cresco LabsFRA:6CQ +1.01%37 Market Cap is €268.1 Mil as of Jul. 02, 2026. GuruFocus rates FRA:6CQ with a GF Score™ of 37/100 and a GF Value™ of €0.78 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 1,024 Drug Manufacturers companies, Cresco Labs ranks better than 54.1% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Cresco Labs's share price for the quarter that ended in Mar. 2026 was €0.6485. Cresco Labs's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 370.5 Mil. Therefore, Cresco Labs's market cap for the quarter that ended in Mar. 2026 was €240.3 Mil.
Cresco Labs's quarterly market cap
declined
from Sep. 2025 (€401.4 Mil) to Dec. 2025 (€354.9 Mil) and
declined
from Dec. 2025 (€354.9 Mil) to Mar. 2026 (€240.3 Mil).
Cresco Labs's annual market cap
declined
from Dec. 2023 (€402.6 Mil) to Dec. 2024 (€269.5 Mil) but then
increased
from Dec. 2024 (€269.5 Mil) to Dec. 2025 (€354.9 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cresco Labs's Enterprise Value for Today is €677.0 Mil.
Cresco Labs (FRA:6CQ) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Cresco Labs Market Cap Related Terms
Cresco Labs Market Cap Historical Data
* Premium members only.
The historical data trend for Cresco Labs's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Cresco Labs's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cresco Labs Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cresco Labs's Market Cap distribution charts can be found below:
* The bar in red indicates where Cresco Labs's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Cresco Labs's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cresco Labs (FRA:6CQ) has a Market Cap of €268.1 Mil as of Jul. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cresco Labs and its competitors. According to the industry distribution chart, Cresco Labs ranks #470 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 45.9%.
Is Cresco Labs' Market Cap too high?
Cresco Labs' current Market Cap is €268.1 Mil. Based on the distribution chart, Cresco Labs ranks #470 out of 1024 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Cresco Labs has a GF Score™ of 37/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cresco Labs' Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cresco Labs ranks #470 out of 1024 companies for Market Cap. This puts Cresco Labs in the upper half of its industry. The industry median Market Cap is 212.74. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 212.74, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cresco Labs and its competitors. For the Drug Manufacturers industry, the median Market Cap is 212.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cresco Labs's current Market Cap is €268.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cresco Labs stock overvalued right now?
Based on GuruFocus' analysis, Cresco Labs (FRA:6CQ) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.78, compared to a current price of €0.70 — trading 10.6% below its estimated fair value. The current Market Cap is €268.1 Mil. Cresco Labs' overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Cresco Labs (FRA:6CQ), the current Market Cap is €268.1 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cresco Labs (FRA:6CQ) Overvalued in 2026?
Based on GuruFocus' analysis, Cresco Labs stock appears to be undervalued.
The current stock price of €0.70 is trading 10.6% below its estimated GF Value™ of €0.78.
GuruFocus considers Cresco Labs to be Modestly Undervalued.
Key valuation signals for FRA:6CQ:
Market Cap: €268.1 Mil
GF Value™: €0.78 vs. price of €0.70 (10.6% below fair value)
No single metric tells the full story. See the FRA:6CQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture, and sell retail and medical cannabis products through Sunnyside, Cresco Lab's national dispensary brand, and others. The company operates in one segment: the cultivation, manufacturing, distribution, and sale of cannabis. The company's brand includes: Cresco, High Supply, FloraCal Farms, Good News, Wonder Wellness Co., Mindy's, and Remedi.
37GF Score
Get the complete analysis for FRA:6CQ
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:6CQ has been successfully added to your 
